Welcome!
Welcome to the new CancerGRACE.org! Explore our fresh look and improved features—take a quick tour to see what’s new.
Article and Video CATEGORIES
Dr. Gelenis Domingo is a hematologist-oncologist at Memorial Cancer Institute.
She treats patients with a variety of cancers, including hematological malignancies (such as lymphoma and leukemia), blood benign hematology diseases, solid organ tumors (including breast, lung, prostate and colon cancer) and also cares for patients with anemia in pregnancy.
Lung Cancer Video Library Spanish - Domingo - Need of Molecular Diagnosis in Lung Cancer (NGS and PD-L1 Testing)
dbrock
Lung Cancer Video Library Spanish - Domingo - NECESIDAD DE DIAGNOSTICO MOLECULAR EN CANCER DE PULMON (NGS Y pd-l1 TESTS)
Image
We are pleased to offer additions to our Lung Cancer Video Library for our Spanish speaking community.
Para estos videos adicionales a nuestra Biblioteca de videos sobre el cáncer de pulmón producidos en español para nuestra comunidad latina, la Dra. Gelenis Domingo nos brinda información actualizada. En este video, el Dr. Domingo analiza la necesidad del diagnóstico molecular en el cáncer de pulmón (pruebas NGS y PD-L1). Para unirse a la conversación, visite https://cancergrace.org/forum.
*****
For these additional videos to our Lung Cancer Video Library produced in Spanish for our Latino Community, Dr. Gelenis Domingo provides us with up to date information. In this video, Dr. Domingo discusses the need of molecular diagnosis in lung cancer (NGS and PD-L1 testing).
To join the conversation, visit https://cancergrace.org/forum.
Video Language
Please feel free to offer comments and raise questions in our
discussion forums.
Online Community
Bispecifics, or bispecific antibodies, are advanced immunotherapy drugs engineered to have two binding sites, allowing them to latch onto two different targets simultaneously, like a cancer cell and a T-cell, effectively...
The prefix “oligo–” means few. Oligometastatic (at diagnosis) Oligoprogression (during treatment)
There will be a discussion, “Studies in Oligometastatic NSCLC: Current Data and Definitions,” which will focus on what we...
Radiation therapy is primarily a localized treatment, meaning it precisely targets a specific tumor or area of the body, unlike systemic treatments (like chemotherapy) that affect the whole body.
The...
Biomarkers are genetic mutations (like EGFR, ALK, KRAS, BRAF) or protein levels (like PD-L1) in tumor cells that help guide personalized treatment, especially NSCLC, directing patients to targeted therapies or immunotherapies...
Hi Stan! So good to hear from you. I'm sorry for the late response. I too have been out of town with family and missed your post, probably because I was...
It is so good to hear from you! And I am so happy to hear that your holidays have been good and that you are doing well. It sounds like your...
Recent Comments
Oligometastatic vs Oligoprogression
By JanineT GRACE … on
An antibody–drug conjugate (ADC) works a bit like a Trojan horse. It has three main components: